Ossur hf (OSSRu.IC) Quote| Reuters.com
Edition:
United States

Ossur hf (OSSRu.IC)

OSSRu.IC on Iceland Stock Exchange

425.00ISK
28 Jun 2016
Change (% chg)

-- (--)
Prev Close
425.00 kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
56,673
52-wk High
520.00 kr
52-wk Low
405.00 kr

OSSRu.IC

Chart for OSSRu.IC

About

Ossur hf is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company is divided into three market segments: Bracing and Supports, which... (more)

Overall

No Ratios Available.

Financials

  OSSRu.IC Industry Sector
P/E (TTM): -- 41.28 34.69
EPS (TTM): -- -- --
ROI: -- 11.63 14.13
ROE: -- 13.67 15.35

BRIEF-Ossur Managing Director of EMEA sells 160,444 Ossur shares at DKK 25.7/SHR

* Jos van Poorten, Managing Director of EMEA, has on May 19 sold 160,444 Ossur shares at 25.7 Danish crowns ($3.87) per share Source text for Eikon: Further company coverage: ($1 = 6.6356 Danish crowns) (Gdynia Newsroom)

May 19 2016

BRIEF-Ossur Managing Director of EMEA buys 163,793 Ossur shares

* Jos van Poorten, Managing Director of EMEA, bought on May 19 a total of 163,793 Ossur shares at 7.86 Danish crown ($1.18) per share Source text for Eikon: Further company coverage: ($1 = 6.6370 Danish crowns) (Gdynia Newsroom)

May 19 2016

BRIEF-Ossur Q1 EBITDA down at $19 million

* Reported on Wednesday Q1 sales of $114 million versus $114 million year ago

Apr 28 2016

BRIEF-Ossur hf FY EBITDA amounted to $97 million, 20 percent of sales

* FF EBITDA amounted to $97 million, 20 percent of sales Source text for Eikon: Further company coverage: ($1 = 6.6967 Danish crowns) (Gdynia Newsroom)

Feb 18 2016

BRIEF-Össur buys back 1.4 mln own shares for about $4.7 mln

* Says has purchased 1,400,000 own shares (about 0.3 pct of the company's total share capital) at 420 Icelandic crowns per share

Feb 11 2016

BRIEF- Ossur Q4 EBITDA down at $25 million

* Reported on Tuesday Q4 sales of $125 million compared to $129 million in Q4 2014, corresponding to 5 pct growth measured in local currency

Feb 03 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.